Captor Therapeutics ® Investor Relations

      Investor Relations

      Notification of increase in shareholding

      Publication date: 2021-10-15
      Number: RB ESPI 30/2021

      Report No. 30/2021/ESPI

      Legal basis:

      Art. 70 item 1 of the Act on Public Offering - acquisition or disposal of a significant block of shares

      Subject:

      Notification of increase in shareholding

      Content:

      The Management Board of Captor Therapeutics S.A., with its registered office in Wrocław ("Company"), announces that on 15 October 2021 the Company received a notification from funds managed by Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A., pursuant to Article 87(1)(2b) of the Act of 29 July 2005. on Public Offering, Conditions Governing the Introduction of Financial Instruments to Organized Trading, and Public Companies (Journal of Laws of 2009, No. 185, item 1439, as amended), on a total increase in the number of the Company's shares held above 5% of votes at the General Meeting of the Company's Shareholders.

      Enclosed please find the full text of the received notification.


      Attachments: